Biocon informed the bourses that the company, in partnership with Mylan NV, has rolled out Ogivri (trastuzumab-dkst), a biosimilar to Herceptin (trastuzumab) in the US.

As on 2 December,These are the stocks with Selling interest.

As on 2 December,These are the stocks with buying interest.

These Stocks were trading close to their 52-week High as on 2 December 2019.

Gufic Biosciences Limited has been given a patent certificate from the Patent Office, The Government of India, for Parenteral Formulations of Levosimendan.

These Stocks were trading close to their 52-week Low as on 2 December 2019.

The zone of 11,970-12,000 would be a crucial support zone. For the bulls to resume its uptrend, it needs to sustain above the identical high of previous two bars, which is placed between 12,137 and 12,147 levels. Stocks in news: Biocon, RBL Bank, IFCI, United Spirits, Aurobindo Pharma, Bank of Baroda.

The weakness of the preceding two trading sessions is likely to exacerbate with the bears tightening their grip as the US President, Donald Trump, said that he plans to reinstate tariffs on metal imports from Brazil and Argentina. This move, most likely, would ruin previous terms with these countries and amplify a global trade war that the president had appeared ready to scale back.